Clinical Trial Update: Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin in combination with flavopiridol for advanced or recurrent ovarian epithelial cancer and recurrent primary peritoneal cancer.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Flavopiridol (alvocidib)
• Platinol (cisplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-05-14